- Series with complete resolution of left atrial appendage thrombi with apixaban in elderly patients
-
Lee SH, Han S
- KMID: 2373816
- Korean J Intern Med.
- 2016 Mar;31(2):396-398.
- doi: 10.3904/kjim.2015.131
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants
-
Kim KO
- KMID: 2383557
- Korean J Helicobacter Up Gastrointest Res.
- 2016 Dec;16(4):185-188.
- doi: 10.7704/kjhugr.2016.16.4.185
Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These... -
- CITED
-
- Close
- SHARE
-
- Close
- Stroke Update 2011: New Antithrombotics
-
Seo KD, Lee KY
- KMID: 2288709
- Korean J Stroke.
- 2012 Aug;14(2):62-66.
Several new antithrombotic drugs have been developed and approved to use in clinical practice recently. Dabigatran, a direct thrombin inhibitor, and rivaroxaban, a factor Xa inhibitor, have been approved in... -
- CITED
-
- Close
- SHARE
-
- Close
- New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials
-
Jang SW
- KMID: 2383556
- Korean J Helicobacter Up Gastrointest Res.
- 2016 Dec;16(4):178-184.
- doi: 10.7704/kjhugr.2016.16.4.178
For the last half century, vitamin K antagonists (VKAs) have been used for treatment and prevention of venous thromboembolism and stroke prevention in patients with atrial fibrillation. However, their fragile... -
- CITED
-
- Close
- SHARE
-
- Close
- Deep Vein Thrombosis and Neurovascular Injury after Total Hip Arthroplasty
-
Seo YS, Yim SJ
- KMID: 1425043
- Hip Pelvis.
- 2012 Dec;24(4):279-287.
- doi: 10.5371/hp.2012.24.4.279
Deep vein thrombosis (DVT) is a relatively common complication of total hip arthroplasty. DVT can accompany symptoms of pain and swelling of the lower leg, and can lead to fatal... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidural hematoma after total knee arthroplasty in a patient receiving rivaroxaban: A case report
-
Shin S, Kang H, Lee JW, Kim HG, Choi ES
- KMID: 2434207
- Anesth Pain Med.
- 2019 Jan;14(1):102-105.
- doi: 10.17085/apm.2019.14.1.102
Rivaroxaban, a factor Xa inhibitor, is one of the newly developed direct oral anticoagulants (DOAC). In recent times, it has been increasingly used in the prevention of pulmonary embolism in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases
-
Kim HJ, Koo SM, Ham NS, Kim KU, Uh ST, Kim YK
- KMID: 2320494
- Tuberc Respir Dis.
- 2014 Mar;76(3):127-130.
The risk of dying from a pulmonary embolism (PE) is estimated to be about 30% if inotropic support is required and no cardiopulmonary arrest occurs. Fibrinolysis in massive PE is... -
- CITED
-
- Close
- SHARE
-
- Close
- Structure of heavy and light chains of blood coagulation factor VIII (FVIII) involved in the activation of FVIII
-
Oh SH, Kim HW, Kim YJ
- KMID: 2045604
- Exp Mol Med.
- 1997 Jun;29(2):97-102.
Structure of human blood coagulation factor VIII (FVIII) in relation to its activation process was investigated. FVIII was purified from a commercial FVIII concentrate by immunoaffinity chromatography and its dissociated... -
- CITED
-
- Close
- SHARE
-
- Close
- Anaphylactoid Reactions after Thrombokinase Administration: Two cases
-
Kwon YE, Lee JH, Lee KN, Moon JI
- KMID: 2239108
- Korean J Anesthesiol.
- 1996 May;30(5):628-631.
- doi: 10.4097/kjae.1996.30.5.628
The incidence of life-threatening anaphylactoid reactions during anesthesia has been increasing. Specific allergic reactions during anesthesia are usually due to muscle relaxants, barbiturates, local anesthetics, narcotics, radiocontrast media, antibiotics, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advances in the management of venous thromboembolism
-
Ageno W
- KMID: 2252077
- Korean J Hematol.
- 2010 Mar;45(1):8-13.
- doi: 10.5045/kjh.2010.45.1.8
Venous thromboembolism (VTE) is a spectrum of diseases that includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Anticoagulant treatment is the mainstay of therapy for VTE. Unfractionated heparin (UFH)... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients
-
Joung B
- KMID: 2396475
- Korean Circ J.
- 2017 Nov;47(6):833-841.
- doi: 10.4070/kcj.2017.0158
Regulatory approvals of non-vitamin K antagonist oral anticoagulants (NOACs) have been based on large randomized phase III trials evaluating dabigatran, rivaroxaban, apixaban, or edoxaban relative to warfarin for atrial fibrillation... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
-
Jeong HC, Kim TE, Shin KH
- KMID: 2442244
- Transl Clin Pharmacol.
- 2019 Mar;27(1):33-41.
- doi: 10.12793/tcp.2019.27.1.33
Apixaban, an inhibitor of direct factor Xa, is used for the treatment of venous thromboembolic events or prevention of stroke. Unlike many other anticoagulant agents, it does not need periodic... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
-
Brodsky SV, Mhaskar NS, Thiruveedi S, Dhingra R, Reuben SC, Calomeni E, Ivanov I, Satoskar A, Hemminger , Nadasdy G, Hebert L, Rovin B, Nadasdy T
- KMID: 2405114
- Kidney Res Clin Pract.
- 2017 Dec;36(4):387-392.
- doi: 10.23876/j.krcp.2017.36.4.387
Anticoagulant-related nephropathy (ARN) was initially described in patients on warfarin (as warfarin-related nephropathy) and recently in those using dabigatran. Herein, we report clinical history and kidney biopsy findings in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
-
Yang H, Kim SR, Song MJ
- KMID: 2373155
- Clin Mol Hepatol.
- 2016 Dec;22(4):499-502.
- doi: 10.3350/cmh.2016.0016
Cirrhosis can occur with the development of portal vein thrombosis (PVT). PVT may aggravate portal hypertension, and it can lead to hepatic decompensation. The international guideline recommends for anticoagulation treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
-
Lim SY, Jeon K, Kim HJ, Kim SM, Song J, Ha JM, Um SW, Koh WJ, Chung MP, Kim H, Kwon OJ, Suh GY
- KMID: 1786947
- J Korean Med Sci.
- 2013 Mar;28(3):466-471.
- doi: 10.3346/jkms.2013.28.3.466
The aim of this study was to investigate antifactor Xa (aFXa) levels after once daily dose of 40 mg of enoxaparin and to evaluate factors influencing aFXa levels among Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons
-
Kim NK, Kim TK, Kim JM, Chun CH
- KMID: 2350098
- Knee Surg Relat Res.
- 2016 Sep;28(3):207-212.
- doi: 10.5792/ksrr.2016.28.3.207
PURPOSE: The purpose of this study is to provide information on the actual status and prevailing trend of prophylaxis for venous thromboembolism (VTE) following total knee arthroplasty (TKA) in South... -
- CITED
-
- Close
- SHARE
-
- Close
- Study of the Effect of Thromboplastin Preparation ( Thrombokinase ) on the Blood Coagulation
-
Lee YJ, Yoon DM, Cho CH, Park BM
- KMID: 1933179
- Korean J Anesthesiol.
- 1988 Apr;21(2):340-344.
- doi: 10.4097/kjae.1988.21.2.340
Coagulants have been used for a long time to promote the hemostasis during operation. We have carried out the study to see the effect of the thromboplastin preparation. Thrombokinase, on... -
- CITED
-
- Close
- SHARE
-
- Close
- Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
-
Lee JH, Oh YM, Lee SD, Lee JS
- KMID: 2456269
- J Korean Med Sci.
- 2019 Jun;34(21):e160.
- doi: 10.3346/jkms.2019.34.e160
BACKGROUND: Low-molecular-weight heparin (LMWH) is the standard treatment for venous thromboembolism (VTE) in patients with active cancer. However, use of factor Xa inhibitors, such as rivaroxaban, is increasing on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
-
Jung KH, Yu KH, Kim YD, Park JM, Hong KS, Rha JH, Kwon SU, Bae HJ, Heo JH, Lee BC, Yoon BW
- KMID: 2223677
- J Stroke.
- 2015 May;17(2):210-215.
- doi: 10.5853/jos.2015.17.2.210
Cardioembolic stroke related to nonvalvular atrial fibrillation is associated with a high recurrence rate and high mortality and morbidity. In this population, therefore, optimal anticoagulant therapy is required to prevent... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparisons of Bleeding Risks between Rivaroxaban and Dalteparin for Treatment of Venous Thromboembolism in Cancer Patients
-
Kim YK, An SH, Kim JY, Chung JE, Gwak HS
- KMID: 2358234
- Korean J Clin Pharm.
- 2016 Sep;26(3):195-200.
- doi: 10.0000/kjcp.2016.26.3.195
BACKGROUND: Venous thromboembolism (VTE) is a common and life-threating condition in cancer patients. Low molecular weight heparins (LMWH), such as dalteparin, are recommended in the treatment of VTE. Also, rivaroxaban,... -
- CITED
-
- Close
- SHARE
-
- Close
